Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals

Journal of the National Cancer Institute

Volumn 92, Issue 24, 2000, Pages 2009-2017

  Platz, Elizabeth A ^a,d   Rimm, Eric B ^a,b   Willett, Walter C ^a,b   Kantoff, Philip W ^c   Giovannucci, Edward ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ANDROGEN RECEPTOR; CALCITRIOL; CYTOSINE; GUANINE; HORMONE; SEX HORMONE BINDING GLOBULIN; STEROID HORMONE; TRINUCLEOTIDE;

ADULT; AGED; ARTICLE; ASIAN; CANCER INCIDENCE; CANCER RISK; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; DIET; HEALTH PRACTITIONER; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; LIFESTYLE; MALE; NEGRO; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; RISK FACTOR; TRINUCLEOTIDE REPEAT;

EID: 0034694678     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/92.24.2009     Document Type: Article

References (63)

1. Cancer statistics, 2000
2. A prospective study of dietary fat and risk of prostate cancer
3. Calcium and fructose intake in relation to risk of prostate cancer
4. Intake of carotenoids and retinol in relation to risk of prostate cancer
5. A prospective, population-based study of androstenedione, estrogens, and prostatic cancer
6. Longitudinal evaluation of serum androgen levels in men with and without prostate cancer
7. Prospective study of sex hormone levels and risk of prostate cancer
8. Serum androgens and prostate cancer
9. Androgens in serum and the risk of prostate cancer: A nested case-control study from the Janus serum bank in Norway
10. Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia
11. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
12. Insulin-like growth factor I and prostate cancer risk: A population-based, case-control study
13. Vitamin D and prostate cancer: A prediagnostic study with stored sera
14. Prostate cancer and prediagnostic levels of serum vitamin D metabolites
15. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer
16. Serum vitamin D metabolite levels and the subsequent development of prostate cancer
17. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer
18. Polymorphic repeats in the androgen receptor gene: Molecular markers of prostate cancer risk
19. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor
20. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer
21. Test of the National Death Index
22. Diagnosis, staging, and surgical treatment of prostatic carcinoma
23. Carcinoma of the prostate
24. Height, body weight, and risk of prostate cancer
25. A prospective study of physical activity and prostate cancer in male health professionals
26. Smoking and risk of total and fatal prostate cancer in United States health professionals
27. Diabetes mellitus and risk of prostate cancer (United States)
28. A prospective cohort study of vasectomy and prostate cancer in US men
29. Reproducibility and validity of a self-administered physical activity questionnaire for male health professionals
30. Reproducibility and validity of an expanded self-administered semi-quantitative food frequency questionnaire among male health professionals
31. Nutritional epidemiology
32. Age, disease, and changing sex hormone levels in middle-aged men: Results of the Massachusetts Male Aging Study
33. 125I-labeled tracer
34. 125I-labeled tracer
35. Relation of pooled logistic regression to time dependent Cox regression analysis: The Framingham Heart Study
36. Cancer incidence in five continents
37. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States
38. Physiological control of prostatic growth: An overview
39. Serum testosterone levels in healthy young black and white men
40. 5-Alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males
41. Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada
42. Androgen receptor and mechanism of androgen action
43. Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups
44. Androgen receptor gene CAG repeat length varies in a race-specific fashion in men without prostate cancer
45. 3 and vitamin D analogs
46. Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells
47. IGF-binding proteins in human prostate tumor cells: Expression and regulation by 1,25-dihydroxyvitamin D3
48. Control of LNCaP proliferation and differentiation: Actions and interactions of androgens, 1α,25-dihydroxycholecalciferol, all-trans retinoic acid, 9-cis retinoic acid, and phenylacetate
49. Regulation of growth, PSA/PAP and androgen receptor expression by 1α,25-dihydroxyvitamin D3 in the androgen-dependent LNCaP cells
50. Association of prostate cancer with vitamin D receptor haplotypes in African-Americans
51. Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-dihydroxyvitamin D3
52. 3, inhibits the proliferation of primary prostatic epithelial cells
53. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1α,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer
54. Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men
55. Growth factors and cytokines
56. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53- and IGF-independent mechanism
57. Racial differences in insulin-like growth factor binding protein-3 in men at increased risk of prostate cancer
58. SEER cancer statistics review, 1973-1996
59. Differential misclassification arising from nondifferential errors in exposure measurement
60. Retrospective analysis of birthweight and prostate cancer in the Health Professionals Follow-up Study